| Company: | Bioenvision, Inc. |
| Ticker Symbol: | NASD: BIVN |
| Class Period:: | May 1, 2007 to May 28, 2007 |
| Date Filed: | Jul-17-07 |
| Lead Plaintiff Deadline: | Sep-15-07 |
| Court: | Southern District, NY |
| Allegations: |
A class action has been commenced in the United States District Court for the Southern District of New York on behalf of persons who sold Bioenvision, Inc. ("BIVN" or the "Company") (NASDAQ: BIVN) securities during the period between May 1, 2007 through May 28, 2007 (the "Class Period").
The lawsuit charges that defendants violated the federal securities laws by issuing a series of materially false and misleading statements to the market throughout the Class Period about the Company and by failing to disclose material information about the Company's plan to merge with Genzyme, and when the market learned the truth the price of Bioenvision securities increased substantially.
If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.
The lawsuit charges that defendants violated the federal securities laws by issuing a series of materially false and misleading statements to the market throughout the Class Period about the Company and by failing to disclose material information about the Company's plan to merge with Genzyme, and when the market learned the truth the price of Bioenvision securities increased substantially.
If you acquired the securities of the defendants during the Class Period you may, no later than the Lead Plaintiff Deadline shown above, request that the Court appoint you as lead plaintiff through counsel of your choice. You may also choose to remain an absent class member. A lead plaintiff must meet certain requirements.
